• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Intravenous alteplase before endovascular treatment does not improve acute ischemic stroke outcomes

byBoaz WongandHarsh Shah
January 12, 2022
in Emergency, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Patients receiving intravenous alteplase before endovascular treatment had similar disability outcomes of symptomatic intracerebral hemorrhage post-stroke compared to patients not receiving alteplase.

2. The incidence of symptomatic intracerebral hemorrhage post-stroke is similar between patients receiving intravenous alteplase before endovascular treatment and patients not receiving alteplase.

Evidence Rating Level: 1 (Excellent)       

Study Rundown: Endovascular treatment (EVT) is currently the standard of care for patients with acute ischemic stroke due to intracranial vessel occlusion. Some evidence suggests that pre-administration of intravenous alteplase, a thrombolytic medication, may help improve outcomes. In this randomized control trial, patients who had an acute ischemic stroke due to an intracranial proximal occlusion of the anterior circulation were randomized to either receive intravenous alteplase before EVT, or EVT alone. The primary outcome was the functional assessment by modified Rankin scale at 90 days post-treatment. Secondary endpoints assessed the success of cranial reperfusion, decrease in lesion volume on imaging, and quality of life indicators. The study found no significant change in the modified Rankin scale scores between the groups. All other secondary measures also yielded no significant differences between the two patient cohorts. With respect to safety data, mortality was slightly higher in the EVT-alone group and no differences were found in the incidence of symptomatic intracerebral hemorrhage. Overall, the data does not support the addition of alteplase to the standard of care of EVT for patients with acute ischemic stroke. The conclusions of this trial are limited by patient selection as EVT was readily available for all patients in this study, potentially leaving a role of alteplase in more remote stroke scenarios.

Click to read the study in NEJM

Relevant Reading: Preceding intravenous thrombolysis facilitates endovascular mechanical recanalization in large intracranial artery occlusion

RELATED REPORTS

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

In-Depth [randomized controlled trial]: In this multi-center, randomized control trial, 539 consenting patients with acute ischemic stroke due to an intracranial proximal occlusion of the anterior circulation were enrolled into the trial and randomized in a 1:1 ratio into two groups: one receiving 0.9mg/kg intravenous ateplase within 4.5 hours of symptom incidence prior to EVT or received EVT alone. The primary objective was to evaluate the superiority of alteplase on functional response as measured by the modified Rankin scale at 90 days follow-up by common odds ratio. The study found that no significant differences in median scores between groups (adjusted common OR: 0.84, 95%CI [0.62-1.15], P=0.28). Secondary outcomes assessed improved stroke outcomes such as the proportion of incidence of recanalization, reperfusion success, and quality of life measures. The analysis also found no significant differences in these measures between the two groups. The EVT-alone group experienced a slightly higher proportion of mortality within 90 days (20.5% vs. 15.8%, OR: 1.39, 95% CI [0.84-2.3]), but similar proportions of symptomatic intracerebral hemorrhage (5.9% vs. 5.3%, OR: 1.3, 95% CI [0.6-2.81]). All other safety endpoints and complications were not significantly different. Taken together, the study concludes that intravenous alteplase administration prior to EVT was not superior, nor non-inferior to the standard of care treatment regimen of EVT alone in improving functional outcomes within 90 days.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alteplasecranial reperfusionendovascular treatmentischemic strokeRankin Scale
Previous Post

#VisualAbstract: Drug-eluting stents reduced in-stent restenosis risk for high-grade intracranial atherosclerotic stenosis lesions compared to bare-metal stents

Next Post

#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas

RelatedReports

Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

July 4, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Stroke expansion following intra-arterial therapy may explain worse outcomes
Emergency

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

May 30, 2025
Use of aspirin for primary prevention linked to increased risk of intracranial hemorrhage
Cardiology

Direct oral anticoagulants increase bleeding risk after intracerebral hemorrhage in patients with atrial fibrillation

May 2, 2025
Next Post
#VisualAbstract: Acral lentiginous melanoma may be associated with higher rates of sentinel lymph node positivity compared to other melanoma subtypes

#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Carbon ion radiotherapy for chordomas associated with similar oncologic outcomes and reduced adverse events compared to en bloc resection

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Balancing vaccination rates with the lifting of lockdown restrictions may mitigate COVID-19 transmissibility

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer
  • MLC901 may be effective in treatment of post-concussion symptoms in phase III study
  • Risk of dementia increased with gabapentin prescription in back pain patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.